MagDI Italian Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

May 31, 2026

Conditions
ObesityType 2 Diabetes Mellitus (T2DM)Anastomosis
Interventions
DEVICE

Magnet System, DI Biofragmentable

Anastomoses achieved by magnetic compression.

Trial Locations (4)

Unknown

Policlinico San Marco, Bergamo

Maria Cecilia Hispital, Cotignola

San Raffaelle Hospital, Milan

Ospedale Evangelco Betania, Naples

Sponsors
All Listed Sponsors
lead

GT Metabolic Solutions, Inc.

INDUSTRY

NCT06613711 - MagDI Italian Study | Biotech Hunter | Biotech Hunter